Last Update Time:
28-Feb-2025 16:00:00
ISIN:
INE621H01010
Sector:
Financial Services
Symbol:
RELIGARE
Religare Enterprises Limited
₹229.50
₹2.45
(1.08%)
▲
Prev. Close
₹227.05
Open
₹223.00
Close
₹224.76
Range
₹218.03 - ₹240.98
High
₹229.50
Low
₹214.80
Ind. Close
₹0.00
VWAP
₹219.97
The current stock price of Religare Enterprises Limited is ₹229.50, with a target price range between ₹218.03 and ₹240.98. The stock has experienced a price change of ₹2.45 (1.08%), reflecting recent market volatility.
Today's opening price was ₹223.00, while the previous close stood at ₹227.05.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Religare Enterprises Limited Price Chart
Religare Enterprises Limited Pre Open Market Overview: 28-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 223
- Previous Close Price: 227.05
- Change: -4.05%
- Total Traded Volume: 2,820
- Total Buy Quantity: 27,733
- Total Sell Quantity: 39,706
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 222.00 | 45.00 | 0.00 |
| 222.10 | 100.00 | 0.00 |
| 222.20 | 100.00 | 0.00 |
| 222.30 | 430.00 | 0.00 |
| 222.40 | 60.00 | 0.00 |
| 223.00 | 0.00 | 1,796.00 |
| 223.90 | 0.00 | 100.00 |
| 224.50 | 0.00 | 100.00 |
| 224.93 | 0.00 | 50.00 |
| 225.90 | 0.00 | 50.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 27733
Total Sell Quantity: 39706
Shareholding Patterns of Religare Enterprises Limited
Key Trade Statistics of Religare Enterprises Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 41.63 |
| Traded Value (₹ Cr.) | 91.58 |
| Total Market Cap (₹ Cr.) | 7,587.40 |
| Free Float Market Cap (₹ Cr.) | 7,513.42 |
| Impact cost | 0.08 |
| Quantity Traded | 4,163,310.00 |
| Deliverable Quantity | 2,246,860.00 |
| % of Quantity to Traded | 53.97 |
| Security VaR | 17.15 |
| Index VaR | N/A |
| VaR Margin | 17.15 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 20.65 |
| Face Value | 10 |
Key Price Statistics of Religare Enterprises Limited
The 52-week high for Religare Enterprises Limited was ₹320.00, recorded on 17-Dec-2024. On the other hand, the 52-week low stands at ₹201.60, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹272.46, and the lower band is ₹181.64. The price band is 20%.
The stock's daily volatility stands at 2.64, while the annualized volatility is 50.44. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (17-Dec-2024) | 320.00 |
| 52 Week Low (04-Jun-2024) | 201.60 |
| Upper Band | 272.46 |
| Lower Band | 181.64 |
| Price Band (%) | 20 |
| Daily Volatility | 2.64 |
| Annualised Volatility | 50.44 |
| Tick Size | 0.01 |
Key Securities Statistics of Religare Enterprises Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 21-Nov-2007 |
| Adjusted P/E | 240.65 |
| Symbol P/E | 34.89 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Financial Services |
| Sector | Financial Services |
| Industry | Finance |
| Basic Industry | Investment Company |
Security Status of Religare Enterprises Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Religare Enterprises Limited
| Subject | Date |
|---|---|
| Updates | 28-Feb-2025 |
| Updates | 27-Feb-2025 |
| Updates | 26-Feb-2025 |
| General Updates | 26-Feb-2025 |
| Change in Director(s) | 26-Feb-2025 |
| Updates | 21-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 21-Feb-2025 |
| Change in Auditors | 21-Feb-2025 |
Corporate Actions of Religare Enterprises Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 24-Dec-2024 |
| 10 | Annual General Meeting | 20-Sep-2023 |
| 10 | Annual General Meeting | 15-Sep-2022 |
| 10 | Annual General Meeting | 21-Sep-2021 |
| 10 | Annual General Meeting | 09-Dec-2020 |
| 10 | Annual General Meeting | 18-Sep-2019 |
| 10 | Annual General Meeting | 11-Sep-2018 |
| 10 | Annual General Meeting | 12-Sep-2017 |
| 10 | Annual General Meeting | 25-Aug-2016 |
| 10 | Annual General Meeting | 03-Sep-2015 |
| 10 | Annual General Meeting | 03-Sep-2014 |
| 10 | Annual General Meeting | 05-Sep-2013 |
| 10 | Annual General Meeting | 23-Aug-2012 |
| 10 | Annual General Meeting | 30-Aug-2011 |
| 10 | Annual General Meeting | 05-Aug-2010 |
| 10 | Int Div-Rs.2/- Per Share | 30-Mar-2010 |
| 10 | Rights 2:3@Prem Rs.345/- | 15-Jan-2010 |
| 10 | Annual General Meeting | 17-Sep-2009 |
| 10 | Agm/Dividend - 11% | 12-Sep-2008 |
Board Meetings of Religare Enterprises Limited
Financial Results of Religare Enterprises Limited
Company Directory of Religare Enterprises Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.religare.com | Registered Office | 1407, 14th Floor Chiranjiv Tower, 43 Nehru Place New Delhi |
NEW DELHI |
| www.religare.com | Transfer Agent | Karvy Computershare Pvt. Ltd Plot no 17 to 24, Vithal Rao Nagar, Madhapur |
HYDERABAD |
Insider Trading of Religare Enterprises Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Rashmi Saluja | 150868111 | Pledge Revoke |
| 7(2) | Rashmi Saluja | 152346574 | Sell |
| 7(2) | Rashmi Saluja | 131502667 | Pledge Revoke |
| 7(2) | Rashmi Saluja | 142113947 | Pledge Revoke |
| 7(2) | Rashmi Saluja | 132902202 | Sell |
| 7(2) | Rashmi Saluja | 141984677 | Sell |
| 7(2) | Shalabh Garg` | 1090860 | Sell |
| 7(2) | Shalabh Garg` | 26507 | Sell |
| 7(2) | Shalabh Garg` | 429500 | Sell |
| 7(2) | Shalabh Garg` | 429000 | Sell |
| 7(2) | Shalabh Garg` | 438900 | Sell |
| 7(2) | Shalabh Garg` | 1095000 | Sell |
| 7(2) | Shalabh Garg` | 660750 | Sell |
| 7(2) | Shalabh Garg` | 1100000 | Sell |
| 7(2) | Rajesh Sharma | 10053655 | Sell |
| 7(2) | Rajesh Sharma | 6799098 | Sell |
| 7(2) | Rajesh Sharma | 6694500 | Pledge Revoke |
| 7(2) | Nitin Aggarwal | 35459689 | Sell |
| 7(2) | Rajesh Sharma | 13089000 | Sell |
| 7(2) | Rajesh Sharma | 13106800 | Pledge Revoke |
Annual Reports of Religare Enterprises Limited
Investor Complaints of Religare Enterprises Limited
Event Calendar of Religare Enterprises Limited
| Purpose | Details |
|---|---|
| Board meeting Cancelled | The Company has informed the Exchange that the meeting of Committee of Directors of the Company scheduled for October 29, 2008 has been cancelled and a Board Meeting is scheduled to be held on October 30, 2008 inter alia, to consider, approve and take on record the Standalone Un-audited Financial Results of the Company for the quarter ended September 30,2008. |
| Rights Issue | The Board of Directors of the Company will reconsider the terms for the proposed Rights Issue of the Company on March 25, 2009 which were earlier decided on October 30, 2008. |
| Rights Issue | Inter alia consider the raising of funds through issuance of Equity Shares on rights basis (Rights Issue) to the existing Shareholders of the Company. |
| Results | Inter-alia, to consider and approve the Annual Audited Standalone & Consolidated Financial Results of the Company for the financial year ended March 31, 2013. |
| Results | Inter-alia, to consider and approve the Un-audited Standalone & Consolidated Financials of the Company for the quarter ended June 30, 2013. |
| Results | Inter-alia, to consider and approve the Un-audited Standalone & Consolidated Financials of the Company for the quarter ended September 30, 2013. |
| Results | Inter-alia, to consider and approve the Un-audited Standalone & Consolidated Financials of the Company for the quarter ended December 31, 2013. |
| Results | Inter-alia, to consider and approve the annual audited Standalone & Consolidated Financials of the Company for the financial year ended March 31, 2014. Further we would like to inform you that Trading Window for dealing in the shares of the Company shall remain closed for the period from May 07, 2014 to June 02, 2014 (both days inclusive). |
| Results | inter-alia to consider and approve quarterly un-audited standalone & consolidated financials of the Company for the quarter ended June 30, 2014. Further we would like to inform you that trading window for dealing in the shares of the Company shall remain closed for the period from July 10, 2014 to August 02, 2014 (both days inclusive) |
| Results | inter-alia, to consider and approve the quarterly un-audited Standalone & Consolidated Financials of the Company for the quarter ended September 30, 2014. Further that Trading Window for dealing in the shares of the Company shall remain closed for the period from October 08, 2014 to November 09, 2014 (both days inclusive). |
| Results | Inter-alia, to consider and approve the quarterly un-audited Standalone & Consolidated Financials of the Company for the quarter ended December 31, 2014. |
| Results | inter-alia, to consider and approve the annual Audited Standalone & Consolidated Financials of the Company for the year ended March 31, 2015. |
| Results | inter-alia, to consider and approve the quarterly un-audited Standalone & Consolidated Financial results of the Company for the quarter ended June 30, 2015. |
| Results | Inter-alia, to consider and approve the quarterly un-audited Standalone & Consolidated Financial results of the Company for the quarter ended on September 30, 2015. |
| Results | Inter-alia, to consider and approve the quarterly un-audited Standalone & Consolidated Financial results of the Company for the quarter ended on December 31, 2015. |
| Raising of Funds | The Meeting of Investment and Borrowing Committee of Board of Directors of the Company is scheduled to be held on March 22, 2016 to consider and approve the raising of funds through issue of Non-Convertible Debentures ( NCD ) on private placement basis |
| Results | Inter-alia, to consider and approve the Annual Audited Standalone & Consolidated Financials of the Company for the year ended March 31, 2016. |
| Results/Others | To consider and approve the Audited Financial Results for the year ended March 31, 2016, the Board will also consider and approve the proposal of raising of funds by issuance of Non-convertible Preference Shares on Private Placement basis which will be subject to approval of shareholders. |
| Results/Others | Inter-alia, to consider and approve the Un-audited Standalone & Consolidated Financials of the Company for the quarter ended on June 30, 2016. The Board will also consider the proposal to seek approval of shareholders for raising of funds through issue of non-convertible debentures on private placement basis. Further, Company would like to inform that Trading Window for dealing in the shares of the Company shall remain closed for the period from July 12, 2016 to August 01, 2016 (both days inclusive). |
| Results | inter-alia, to consider and approve the Un-audited Standalone Financials Results of the Company for the quarter ended on September 30, 2016. |
| Results | inter-alia, to consider and approve the Un-audited Standalone Financials Results of the Company for the quarter ended on December 31, 2016. Further, that Trading Window for dealing in the shares of the Company shall remain closed for the period from January 30, 2017 to February 13, 2017 (both days inclusive). |
| Results | inter-alia, to consider and approve the audited Standalone & Consolidated Financial Results of the Company for the year ended March 31, 2017. Further that Trading Window for dealing in the shares of the Company shall remain closed for the period from May 08, 2017 to May 26, 2017 (both days inclusive). |
| Results | inter-alia, to consider and approve the audited Standalone & Consolidated Financial Results of the Company for the year ended March 31, 2017. |
| Results/Others | Inter-alia, to consider and approve the Un-audited Standalone Financial Results of the Company for the quarter ended on June 30, 2017. The Board will also consider the proposal to seek approval of shareholders for raising of funds through issue of non-convertible debentures on private placement basis. |
| Raising of Funds | to consider and approve the raising of funds through issue of Non-Convertible Debentures ("NCD") on private placement basis. |
| Results | inter alia, to consider and approve the Un-audited Standalone Financial Results of the Company for the Company for the quarter ended September 30, 2017. |
| Results | Inter alia to consider and approve the Un-audited standalone financial results of the Company for the quarter ended December 31, 2017. |
| Board meeting Rescheduled | RELIGARE : 14-Feb-2018 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 08, 2018 Inter alia to consider and approve the Un-audited standalone financial results of the Company for the quarter ended December 31, 2017. The Company has now informed the Exchange that the aforesaid Board Meeting has been postponed and now the Meeting of the Board of Directors of the Company will be held on February 14, 2018. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | inter alia , To consider and approve the Un-audited Standalone financial results for the Company for the quarter ended September 30, 2018. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | RELIGARE : 08-Nov-2019 : The Company has informed the Exchange that a Board meeting to be held on November 06, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 08, 2019, To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Religare Enterprises Limited has informed the Exchange about Board Meeting to be held on 25-May-2022 to consider Annual Audited financial statements for the period ended March 2022 |
| Financial results | Religare Enterprises Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Religare Enterprises Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve Standalone and Consolidated Un-Audited Financial Results of the Company for the Quarter ended December 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Religare Enterprises Limited
Voting Results of Religare Enterprises Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 07-FEB-2025 | AGM | To Consider & Adopt Audited Financial Statements (including Consolidated Financial Statements) and the Report of Board of Directors and Auditors thereon for the yearnended March 31, 2024 |
| 07-FEB-2025 | AGM | To appoint Statutory Auditors and to fix their remuneration |
| 07-FEB-2025 | AGM | To appoint a Director in place of Dr. Rashmi Saluja (DIN: 01715298), who retires by rotation and being eligible, offers herself for re-appointment |
| 07-FEB-2025 | AGM | To Consider & Adopt Audited Financial Statements (including Consolidated Financial Statements) and the Report of Board of Directors and Auditors thereon for the year |
| 07-FEB-2025 | AGM | To appoint Statutory Auditors and to fix their remuneration |
| 07-FEB-2025 | AGM | To appoint a Director in place of Dr. Rashmi Saluja (DIN: 01715298), who retires by rotation and being eligible, offers herself for re-appointment |
| 21-MAR-2024 | Postal Ballot | Approve the investment by way of subscription of securities of MIC Insurance Web Aggregator Private Limited (￢ﾀﾜMIC￢ﾀﾝ), wholly owned subsidiary of the Company |
| 21-MAR-2024 | Postal Ballot | Amend the Articles of Association of the Company |
| 27-SEP-2023 | AGM | Consider & Adopt Audited Financial Statements (including Consolidated Financial Statements) and the Report of Board of Directors and Auditors thereon for the year ended March 31, 2023 |
| 27-SEP-2023 | AGM | Re-appoint Dr. Rashmi Saluja, who retires by rotation and being eligible, offers herself for re-appointment |
| 28-JUN-2023 | Postal Ballot | Appointment of Mr. Malay Kumar Sinha (DIN: 08140223) as a Director and re-appointment as Non-Executive Independent Director of the Company for a second term of 5 consecutive years |
| 23-MAR-2023 | Postal Ballot | Appointment of Ms. Preeti Madan (DIN: 08384644) as Non-Executive Independent Director of the Company For a term of 5 consecutive years |
| 23-SEP-2022 | AGM | To receive, consider and adopt: nn(a) the Audited Financial Statements of the Company for the financial year ended March 31, 2022 including Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date together with the Reports of the Board of Directors and the Auditors thereon.nn(b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022 including Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date together with the Report of the Auditors thereon.n |
| 23-SEP-2022 | AGM | To approve payment of remuneration on re-appointment to Dr. Rashmi Saluja (DIN: 01715298) as Executive Chairperson of the Company |
| 23-SEP-2022 | AGM | To approve re-appointment of Dr. Rashmi Saluja (DIN: 01715298) as Executive Chairperson of the Company w.e.f. February 26, 2023 |
| 23-SEP-2022 | AGM | To approve revision of remuneration of Dr. Rashmi Saluja (DIN 01715298), Executive Chairperson of the Company w.e.f. April 01, 2022 |
| 23-SEP-2022 | AGM | To amend the Articles of Association of the Company |
| 23-SEP-2022 | AGM | To appoint Mr. Ranjan Dwivedi (DIN: 09185085), as Non-Executive Independent Director of the Company for a term of 5 consecutive years |
| 23-SEP-2022 | AGM | To appoint Mr. Praveen Kumar Tripathi (DIN: 02167497), as Non-Executive Independent Director of the Company for a term of 5 consecutive years |
| 23-SEP-2022 | AGM | To appoint a Director in place of Dr. Rashmi Saluja (DIN: 01715298), who retires by rotation and being eligible, offers herself for re-appointment |
FAQs on Religare Enterprises Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.